Oric Pharmaceuticals Company Insiders
| ORIC Stock | USD 9.59 0.47 5.15% |
Oric Pharmaceuticals employs about 112 people. The company is managed by 11 executives with a total tenure of roughly 262 years, averaging almost 23.0 years of service per executive, having 10.18 employees per reported executive. Evaluation of Oric Pharmaceuticals' management performance can provide insight into the firm performance.
Oric |
Oric Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.2922) % which means that it has lost $0.2922 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4598) %, meaning that it created substantial loss on money invested by shareholders. Oric Pharmaceuticals' management efficiency ratios could be used to measure how well Oric Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Oric Pharmaceuticals Workforce Comparison
Oric Pharmaceuticals is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,375. Oric Pharmaceuticals holds roughly 112 in number of employees claiming about 8% of equities under Health Care industry.
Oric Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Oric Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Oric Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Oric Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Oric Pharmaceuticals Notable Stakeholders
An Oric Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Oric Pharmaceuticals often face trade-offs trying to please all of them. Oric Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Oric Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| BA MD | CoFounder Board | Profile | |
| MD MBA | CEO President | Profile | |
| CPA CPA | Chief Officer | Profile | |
| BA BA | CoFounder Board | Profile | |
| Lori Friedman | Chief Officer | Profile | |
| Esq JD | G Counsel | Profile | |
| MS MD | Chief Officer | Profile | |
| Richard Heyman | Independent CoFounder | Profile | |
| Edna Maneval | Senior Development | Profile | |
| Scott Lowe | CoFounder Board | Profile | |
| Daniel Iazzetti | VP People | Profile |
About Oric Pharmaceuticals Management Performance
The success or failure of an entity such as Oric Pharmaceuticals often depends on how effective the management is. Oric Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Oric management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Oric management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. The company was incorporated in 2014 and is headquartered in South San Francisco, California. Oric Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.
Please note, the presentation of Oric Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Oric Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Oric Pharmaceuticals' management manipulating its earnings.
Oric Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Oric Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Oric Pharmaceuticals within its industry.Oric Pharmaceuticals Manpower Efficiency
Return on Oric Pharmaceuticals Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 899.1K | |
| Net Loss Per Executive | 9.2M | |
| Working Capital Per Employee | 1.7M | |
| Working Capital Per Executive | 17.5M |
Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |